FDA advisory panel overwhelmingly backs Abbott's Triclip - Yahoo Finance

Retrieved on: 2024-02-14 18:43:25

Tags for this article:

Cardiac surgery

Heart valves

Cardiology

Valvular heart disease

Prosthetics

Edwards Lifesciences

Tricuspid valve

Transcatheter aortic valve replacement

Click the tags to see associated articles and topics

FDA advisory panel overwhelmingly backs Abbott's Triclip - Yahoo Finance. View article details on hiswai:

Summary

The article discusses FDA panel support for Abbott's Triclip, a MedTech innovation targeting tricuspid regurgitation alongside Edwards Lifesciences' similar heart valve devices, denoting advancements in cardiology, particularly cardiac surgery for valvular heart disease.

Article found on: finance.yahoo.com

View Original Article